Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens
- 1 June 1983
- Vol. 51 (11), 2024-2030
- https://doi.org/10.1002/1097-0142(19830601)51:11<2024::aid-cncr2820511111>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycinCancer, 1980
- Advanced ovarian cancer correlation of histologic grade with response to therapy and survivalCancer, 1980
- Toxicity of Cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydrationCancer, 1980
- Ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1979
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Second-look operation in ovarian carcinoma.PostchemotherapyCancer, 1976
- Chemotherapy of advanced ovarian carcinoma: A prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideGynecologic Oncology, 1974
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972